Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects
Clinical trial NCT03440424 · COMPLETED
Trial details
- NCT number
- NCT03440424
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-26
- Primary completion
- 2018-04-23
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.